---
figid: PMC9162488__nihms-1810817-f0002
figtitle: Allicin, a Potent New Ornithine Decarboxylase Inhibitor in Neuroblastoma
  Cells
organisms:
- Saccharomyces cerevisiae
- Allium sativum
- Syzygium aromaticum
- Escherichia coli
- Pseudomonas syringae
- Homo sapiens
- Mus musculus
- Trypanosoma brucei gambiense
pmcid: PMC9162488
filename: nihms-1810817-f0002.jpg
figlink: /pmc/articles/PMC9162488/figure/F1/
number: F1
caption: Polyamine biosynthesis in cancer cell proliferation. (A) Chemical structures
  of allicin and DFMO. (B) Simplified polyamine (putrescine, spermidine, spermine)
  pathway depicting where ODC inhibition by allicin and DFMO block the production
  of polyamines. MYCN is a key transcription factor that drives proliferation of NB
  and directly transactivates the ODC1 gene via E-box elements. DFMO (aka eflornithine)
  is currently the only ODC inhibitor approved by the FDA for clinical use.
papertitle: Allicin, a Potent New Ornithine Decarboxylase Inhibitor in Neuroblastoma
  Cells.
reftext: Chad R. Schultz, et al. J Nat Prod. ;83(8):2518-2527.
year: '2020'
doi: 10.1021/acs.jnatprod.0c00613
journal_title: Journal of natural products
journal_nlm_ta: J Nat Prod
publisher_name: ''
keywords: Natural products | Allicin | Neuroblastoma | ODC inhibitor | Apoptosis |
  Polyamines
automl_pathway: 0.9060595
figid_alias: PMC9162488__F1
figtype: Figure
organisms_ner:
- Mus musculus
redirect_from: /figures/PMC9162488__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9162488__nihms-1810817-f0002.html
  '@type': Dataset
  description: Polyamine biosynthesis in cancer cell proliferation. (A) Chemical structures
    of allicin and DFMO. (B) Simplified polyamine (putrescine, spermidine, spermine)
    pathway depicting where ODC inhibition by allicin and DFMO block the production
    of polyamines. MYCN is a key transcription factor that drives proliferation of
    NB and directly transactivates the ODC1 gene via E-box elements. DFMO (aka eflornithine)
    is currently the only ODC inhibitor approved by the FDA for clinical use.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - oh
  - Odc1
  - Odc-rs1
  - Mycn
---
